Metropolitan Liver Diseases/Gastroenterology Center
Gastroenterology
Dr. Vinod K. Rustgi, MD
|
|
Give Review
Vinod Rustgi works in the field of Gastroenterology. He attended Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine He received 11 awards: "Medical Consultant.", "Co-Chaired Session on Complications of Liver Transplantation", "President", "Fellow", "External Referee", "National Research Service Award in Gastroenterology", "The American Liver Foundation Fellowship", "NSF grant to study Clinical Oncology", "B.A. Magna cum laude", "Super Doctor" and "Fellow (FACG)". Vinod Rustgi is a published doctor and has 68 publications published. The lastest was: 'Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.' Vinod Rustgi accepts Medicare payments and is registered with Medicare.gov.
Publications
- Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic Hepatitis C treated with boceprevir or telaprevir.
- A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1.
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis.
- Randomized study of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 chronic Hepatitis C.
- Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic Hepatitis b with high baseline viral load (? 9 log10 copies/mL).
- Seizures during pegylated interferon and ribavirin therapy for chronic Hepatitis C: observations from the WIN-R trial.
- Noninvasive monitoring of Hepatitis C fibrosis progression.
- Future trends in hepatology: challenges and opportunities.
- Thymalfasin for the treatment of chronic Hepatitis C infection.
- Use of ribavirin in patients with chronic HCV genotype 1: when enough is really enough.
- Role of gender and race mismatch and graft failure in patients undergoing liver transplantation.
- Treatment of acetaminophen-induced Hepatitis and fulminant hepatic failure with extracorporeal sorbent-based devices.
- Viral clearance is associated with improved insulin resistance in genotype 1 chronic Hepatitis C but not genotype 2/3.
- Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of Hepatitis C genotype 1 patients.
- Preliminary study of two antiviral agents for Hepatitis C genotype 1.
- The epidemiology of Hepatitis C infection in the United States.
- Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic Hepatitis C.
- Peginterferon alfa-2a/ribavirin in Hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin.
- Entecavir therapy for lamivudine-refractory chronic Hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.
- Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic Hepatitis C.
- Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic Hepatitis C.
- Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic Hepatitis C pegylated interferon and ribavirin nonresponders.
- Treatment patterns and adherence among patients with chronic Hepatitis C virus in a US managed care population.
- Safety of small molecules in combination with interferon-based therapy for Hepatitis C virus.
- Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic Hepatitis C virus genotype 1.
- Direct economic burden of chronic Hepatitis C virus in a United States managed care population.
- Changes in B-lymphocyte stimulator protein levels during treatment with albinterferon alfa-2b in patients with chronic Hepatitis C who have failed previous interferon ...
- Impact of donor age on graft survival among liver transplant recipients: analysis of the United Network for Organ Sharing database.
- A multicenter study of recombinant human interleukin 12 for the treatment of chronic Hepatitis C virus infection in patients nonresponsive to previous therapy.
- Impact of body mass index on graft failure and overall survival following liver transplant.
- Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic Hepatitis C virus infection who are non-responders to standard...
- Detection of Hepatitis C virus-specific antigens in semen from non-A, non-B Hepatitis patients.
- Therapy of chronic Hepatitis B with recombinant human alpha and gamma interferon.
- NIH conference. Hepatocellular carcinoma.
- Glomerulonephritis caused by chronic Hepatitis B virus infection: treatment with recombinant human alpha-interferon.
- Epidemiology of hepatocellular carcinoma.
- Lymphokines and bile secretion in the rat.
- Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic Hepatitis B.
- Treatment of chronic non-A,non-B Hepatitis with recombinant human alpha interferon. A preliminary report.
- Viral Hepatitis during pregnancy.
- Psychiatric complications of long-term interferon alfa therapy.
- The disposition of 6-deoxyacyclovir, a xanthine oxidase-activated prodrug of acyclovir, in the isolated perfused rat liver.
- Patients' reactions to house staff work rounds.
- Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic Cancer.
- Fatal disseminated cytomegalovirus infection in an apparently normal adult.
- Psychiatric manifestations of inflammatory bowel Disease. Critical review and future strategies.
- Hepatitis B virus infection in the acquired immunodeficiency Syndrome.
- Absolute peripheral blood eosinophilia. An early marker for rejection in clinical liver transplantation.
- Spectrum of Hepatitis E virus infection in India.
- Management of hemobilia after liver biopsy in liver transplant recipients.
- HCV RNA in patients with chronic Hepatitis C treated with interferon-alpha.
- Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy a...
- Performance characteristics and results of a large-scale screening program for viral Hepatitis and risk factors associated with exposure to viral Hepatitis B and C: re...
- Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic Hepatitis C. Hepatitis Interventional Therapy Group.
- Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic Hepatitis C. International Hepatitis Interventional Therapy Group.
- Portopulmonary hypertension and the liver transplant candidate.
- Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus Disease following liver transplantation.
- Coronary artery Disease and liver transplantation: the state of the art.
- Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension.
- Treatment of chronic Hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia C...
- Dobutamine stress echocardiography for orthotopic liver transplant evaluation.
- Transplantation of Hepatitis C-positive livers in Hepatitis C-positive patients is equivalent to transplanting Hepatitis C-negative livers.
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic Hepatitis C: a randomised trial.
- Interleukin-11 for thrombocytopenia associated with Hepatitis C.
- Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver Disease.
- Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients.
Schools
Johns Hopkins University School Of Medicine
Baylor College Of Med
Georgetown University
National Insts Health
Stanford University
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Hemorrhoidectomy or Excision of Anal Tags
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Awards
- Medical Consultant.
- Co-Chaired Session on Complications of Liver Transplantation
- President
- Fellow
- External Referee
- National Research Service Award in Gastroenterology
- The American Liver Foundation Fellowship
- NSF grant to study Clinical Oncology
- B.A. Magna cum laude
- Super Doctor
- Fellow (FACG)
Education
-
Johns Hopkins University -
National Institutes of Health Clinical Center -
Stanford University -
Georgetown University Hospital -
Baylor College of Medicine -
Johns Hopkins University School of Medicine -
Yale University
Hospital
-
Inova Fair Oaks Hospital -
Inova Fairfax Hospital
Drug Facts
| NPI NUMBER | 1679589121 | |
| NPPES Provider LastName | RUSTGI | |
| NPPES Provider FirstName | VINOD | |
| NPPES Provider ZIPCode | 220315207 | |
| NPPES Provider State | VA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 227.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679589121 |
| Last Name Of The Provider | RUSTGI |
| First Name Of The Provider | VINOD |
| View All |
Similar Doctors
|
|
Dr. Ahmed Hegab, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard Blosser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Behzad Kalaghchi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol S. Schuffler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Byungki Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tonya L. Adams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter L. Scudera, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth R. Mirkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard C. Ranard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Asma P. Khapra, MD
This Doctor is OpenDoctor Recommended.
|